EP12.01. The Optimal Intervention Timing of Aumolertinib Combined with HFSRT for EGFR Mutated NSCLC Patients with Multiple Brain Metastasess - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Qian Shao
Meta Tag
Speaker Qian Shao
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
metastatic non-small cell lung cancer
multiple brain metastases
lung adenocarcinoma
optimal timing of treatment
local treatment
whole brain radiotherapy
stereotactic radiotherapy
hypo-fractionated stereotactic radiotherapy
tyrosine kinase inhibitors
EGFR mutations
Powered By